BioNexus Gene Lab (BGLC) Competitors $2.83 -0.15 (-5.17%) Closing price 03:57 PM EasternExtended Trading$2.82 0.00 (-0.04%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock BGLC vs. MRAI, ENZ, BRTX, MGRX, OTRK, SSY, ACON, VSEE, DHAC, and ATIPShould you be buying BioNexus Gene Lab stock or one of its competitors? The main competitors of BioNexus Gene Lab include Marpai (MRAI), Enzo Biochem (ENZ), BioRestorative Therapies (BRTX), Mangoceuticals (MGRX), Ontrak (OTRK), SunLink Health Systems (SSY), Aclarion (ACON), Vsee Health (VSEE), Digital Health Acquisition (DHAC), and ATI Physical Therapy (ATIP). These companies are all part of the "healthcare" industry. BioNexus Gene Lab vs. Marpai Enzo Biochem BioRestorative Therapies Mangoceuticals Ontrak SunLink Health Systems Aclarion Vsee Health Digital Health Acquisition ATI Physical Therapy BioNexus Gene Lab (NASDAQ:BGLC) and Marpai (NASDAQ:MRAI) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, profitability, dividends, analyst recommendations, valuation, institutional ownership, community ranking and media sentiment. Which has preferable valuation & earnings, BGLC or MRAI? BioNexus Gene Lab has higher earnings, but lower revenue than Marpai. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBioNexus Gene Lab$9.51M0.53-$2.63MN/AN/AMarpai$34.87M0.57-$28.75M-$1.82-0.73 Do institutionals & insiders believe in BGLC or MRAI? 18.9% of BioNexus Gene Lab shares are held by institutional investors. Comparatively, 49.8% of Marpai shares are held by institutional investors. 0.7% of BioNexus Gene Lab shares are held by insiders. Comparatively, 61.3% of Marpai shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Is BGLC or MRAI more profitable? BioNexus Gene Lab has a net margin of -10.17% compared to Marpai's net margin of -85.70%. Marpai's return on equity of 0.00% beat BioNexus Gene Lab's return on equity.Company Net Margins Return on Equity Return on Assets BioNexus Gene Lab-10.17% -9.93% -8.43% Marpai -85.70%N/A -100.23% Which has more risk & volatility, BGLC or MRAI? BioNexus Gene Lab has a beta of 5.2, indicating that its share price is 420% more volatile than the S&P 500. Comparatively, Marpai has a beta of 4.74, indicating that its share price is 374% more volatile than the S&P 500. Does the media prefer BGLC or MRAI? In the previous week, Marpai had 1 more articles in the media than BioNexus Gene Lab. MarketBeat recorded 2 mentions for Marpai and 1 mentions for BioNexus Gene Lab. Marpai's average media sentiment score of 0.68 beat BioNexus Gene Lab's score of -1.29 indicating that Marpai is being referred to more favorably in the news media. Company Overall Sentiment BioNexus Gene Lab Negative Marpai Positive Does the MarketBeat Community believe in BGLC or MRAI? Marpai received 2 more outperform votes than BioNexus Gene Lab when rated by MarketBeat users. CompanyUnderperformOutperformBioNexus Gene LabN/AN/AMarpaiOutperform Votes266.67% Underperform Votes133.33% SummaryMarpai beats BioNexus Gene Lab on 8 of the 12 factors compared between the two stocks. Get BioNexus Gene Lab News Delivered to You Automatically Sign up to receive the latest news and ratings for BGLC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BGLC vs. The Competition Export to ExcelMetricBioNexus Gene LabMedical laboratories IndustryMedical SectorNASDAQ ExchangeMarket Cap$5.08M$2.91B$5.34B$8.42BDividend YieldN/A31.23%5.21%4.11%P/E RatioN/A12.7826.8519.72Price / Sales0.53160.54387.23121.26Price / CashN/A57.5638.2534.62Price / Book5.144.236.774.51Net Income-$2.63M-$22.21M$3.23B$248.32M7 Day Performance-7.04%1.57%1.81%0.60%1 Month Performance1.29%2.20%10.93%13.18%1 Year Performance-48.28%1.52%17.15%7.39% BioNexus Gene Lab Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BGLCBioNexus Gene Lab0.263 of 5 stars$2.83-5.2%N/A-44.9%$5.08M$9.51M0.0030Negative NewsEarnings ReportMRAIMarpaiN/A$1.30-3.0%N/A-34.0%$19.37M$34.87M-0.49150ENZEnzo BiochemN/A$0.33-14.8%N/A-69.0%$17.03M$29.09M0.00520Gap DownHigh Trading VolumeBRTXBioRestorative Therapies3.3258 of 5 stars$1.71-7.2%$18.00+951.5%+23.0%$12.85M$401,000.00-1.127Analyst RevisionMGRXMangoceuticals0.189 of 5 stars$1.65-4.1%N/A-98.7%$8.53M$615,873.00-0.293Earnings ReportOTRKOntrak2.5234 of 5 stars$1.67-1.7%$45.00+2,593.0%-61.2%$7.05M$10.85M-0.16250News CoverageEarnings ReportGap UpSSYSunLink Health SystemsN/A$0.86-2.0%N/A+42.5%$6.07M$31.23M6.161,376News CoverageAnalyst ForecastACONAclarion1.649 of 5 stars$7.40-2.6%$11,758.50+158,798.6%-99.8%$4.31M$45,724.000.007Earnings ReportVSEEVsee Health1.1941 of 5 stars$1.17+0.1%$5.00+327.0%N/A$4.22M$6.38M0.00N/ADHACDigital Health AcquisitionN/A$1.17-3.3%N/A-91.4%$4.22MN/A0.002,021Gap UpATIPATI Physical TherapyN/A$0.83-2.9%N/A-81.3%$3.66M$741.86M-0.045,600 Related Companies and Tools Related Companies MRAI Alternatives ENZ Alternatives BRTX Alternatives MGRX Alternatives OTRK Alternatives SSY Alternatives ACON Alternatives VSEE Alternatives DHAC Alternatives ATIP Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BGLC) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredThe Collapse Has Already Started — Your 401(k) Is NextThere's a major heist happening on American wealth in real time. Except this one doesn't involve masks or v...American Hartford Gold | SponsoredElon’s 2025 Silver Crisis (What It Means for You)Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThe DOJ Just Said Your Money Isn’t YoursWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioNexus Gene Lab Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioNexus Gene Lab With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BGLC Stock Free BGLC Stock Alerts